Related Experiment Video
Updated: Jan 29, 2026

Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin
Published on: September 12, 2019
Ferroptosis in Myocardial Fibrosis: Mechanisms and Therapeutic Insights
Xuefeng Lin1, Weijun Li1, Jiahao Ye1
1College of Chinese Medicine, Hunan University of Chinese Medicine, Changsha 410208, China.
Abstract:
Myocardial fibrosis (MF) is a common pathological feature of diverse cardiac disorders and is a key driving factor of cardiac dysfunction. It is marked by excessive deposition of extracellular matrix (ECM) proteins, particularly collagen type I and III, and a prolonged activation of cardiac fibroblasts. However, the molecular drivers of this process remain undetermined. Ferroptosis is an iron-catalyzed, lipid-peroxidation-dependent mode of regulated cell death. Research indicates that ferroptosis is significantly involved in the onset and advancement of MF; consequently, developing therapies that selectively modulate ferroptosis presents a promising direction of treatment options. Therefore, this paper systematically discusses the mechanisms associated with ferroptosis to explore the link between ferroptosis and MF from multiple dimensions, including iron metabolism disorders, lipid peroxidation, imbalance of glutathione metabolism, and the dysregulated activation of ferroptosis regulatory pathways, to provide innovative perspectives for the study of the specific molecular mechanisms and treatment of MF. Method: By retrieving the literature on the mechanism of ferroptosis in MF published in PubMed and Web of Science databases from 2020 to July 2025, the mechanism of action was systematically analyzed and reviewed.
Insights
Ferroptosis, a cell death process, is increasingly linked to myocardial fibrosis (MF). Targeting ferroptosis mechanisms offers a novel therapeutic strategy for treating cardiac dysfunction and MF.
Area of Science:
- Cardiovascular Research
- Cell Death Mechanisms
- Biomedical Science
Background:
- Myocardial fibrosis (MF) is a pathological hallmark of cardiac disorders, driven by extracellular matrix deposition and fibroblast activation.
- The precise molecular mechanisms underlying MF progression remain largely unknown.
- Ferroptosis, a regulated cell death pathway involving iron and lipid peroxidation, is emerging as a significant factor in MF.
Purpose of the Study:
- To systematically review the intricate mechanisms linking ferroptosis to myocardial fibrosis.
- To explore ferroptosis's role in MF pathogenesis from multiple molecular dimensions.
- To offer novel perspectives for understanding and treating MF.
Main Methods:
- Comprehensive literature search of PubMed and Web of Science databases.
- Focus on studies published from 2020 to July 2025.
- Systematic analysis and review of ferroptosis mechanisms in MF.
Main Results:
- Ferroptosis is implicated in the onset and advancement of myocardial fibrosis.
- Disruptions in iron metabolism, lipid peroxidation, and glutathione balance are key contributors.
- Dysregulated ferroptosis pathways are central to MF development.
Conclusions:
- Modulating ferroptosis presents a promising therapeutic avenue for myocardial fibrosis.
- Understanding ferroptosis mechanisms is crucial for developing targeted MF treatments.
- This review provides innovative insights into MF molecular mechanisms and potential therapies.
More Related Videos
06:15A Hydrogel Construct and Fibrin-based Glue Approach to Deliver Therapeutics in a Murine Myocardial Infarction Model.
Published on: June 14, 2015
09:44Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Therapeutic Index
Cystic Fibrosis: Management
Sinus disease and chronic...
Therapeutic Communication
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Microorganisms in Medicine and Therapeutics